Detalhe da pesquisa
1.
Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study.
BMC Infect Dis
; 23(1): 408, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322426
2.
CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.
Cell Mol Biol (Noisy-le-grand)
; 65(8): 18-22, 2019 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32133974
3.
Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.
Int Health
; 15(4): 357-364, 2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653710
4.
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
J Clin Tuberc Other Mycobact Dis
; 27: 100299, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35146133
5.
Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda.
Am J Trop Med Hyg
; 105(1): 47-53, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999845
6.
Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control.
PLoS One
; 15(4): e0231372, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32324750
7.
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.
Am J Trop Med Hyg
; 103(4): 1443-1446, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618257
8.
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.
Lancet Microbe
; 1(2): e74-e83, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544156
9.
Management of falsepositive rifampicin resistant Xpert MTB/RIF - Authors' reply.
Lancet Microbe
; 1(6): e239, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544219